Peripheral Arterial Disease  >>  cilostazol  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cilostazol / Generic mfg.
MASCOT, NCT00300339 / 2005-003119-62: Mixed Antagonist of Serotonin for Claudication Optimal Therapy

Completed
2
599
US, Canada, Europe, RoW
SL650472, Clopidogrel
Sanofi
Intermittent Claudication
12/07
12/07
ACCELA, NCT00443287 / 2006-004275-35: Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease

Completed
2
553
US, Canada, Europe, RoW
ataciguat (HMR1766), placebo, cilostazol
Sanofi
Intermittent Claudication
10/08
10/08
NCT00783081: Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

Completed
2
387
US, RoW
K-134, Cilostazol 100 mg BID, Placebo
Kowa Research Institute, Inc.
Intermittent Claudication
07/10
07/10

Download Options